Neal Andruska

Emory University — United States

Medicine · Health Sciences

17h-index928citations58works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(17), Prostate Cancer Treatment and Research(16), Advanced Radiotherapy Techniques(15), Endoplasmic Reticulum Stress and Disease(6), Antenna Design and Analysis(5)

Publications58 total

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
Clinical and Translational Radiation Oncology·2023· 19 citedOpen Access
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Clinical Genitourinary Cancer·2023· 2 cited
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation
Blood Advances·2023· 9 citedOpen Access
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
Clinical and Translational Radiation Oncology·2023· 9 citedOpen Access
Differences in radiation-induced heart dysfunction in male versus female rats
International Journal of Radiation Biology·2023· 9 citedOpen Access
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
Cureus·2023· 1 citedOpen Access
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
International Journal of Radiation Oncology*Biology*Physics·2022
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold
Breast Cancer Targets and Therapy·2022· 29 citedOpen Access
Generative adversarial neural networks augment marker and pathway analysis of treatment resistant HPV+ head and neck squamous cell carcinoma.
Journal of Clinical Oncology·2022· 2 cited
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy
Brachytherapy·2022· 3 citedOpen Access
Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders
Practical Radiation Oncology·2022· 3 cited
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
Journal of the National Comprehensive Cancer Network·2022· 3 citedOpen Access
External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
Journal of Clinical Oncology·2022
Survival outcomes in men with unfavorable intermediate-risk and high-risk prostate cancer treated with prostate-only versus whole pelvic radiation therapy.
Journal of Clinical Oncology·2022
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer
Brachytherapy·2022· 1 citedOpen Access
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer
Clinical Genitourinary Cancer·2021· 5 citedOpen Access
Comparative Effectiveness of the Brachytherapy Boost and Androgen Deprivation Therapy for African-American Men with Unfavorable Intermediate-Risk Prostate Cancer Treated With External Beam Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2021Open Access
Can EBRT Dose-Escalation Above 80 Gy Yield Comparable Survival Rates Relative to EBRT Plus Brachytherapy Boost in Men With Unfavorable Intermediate-Risk Prostate Cancer?
International Journal of Radiation Oncology*Biology*Physics·2021Open Access
Development of Radioresistant CAR T Cells for Solid Tumor Therapeutics
International Journal of Radiation Oncology*Biology*Physics·2021· 1 citedOpen Access
Characterization of a Novel Radiopaque Perirectal Hydrogel Spacer for Prostate Cancer Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2021· 3 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Brian C. Baumann(20), Randall Brenneman(18), Hiram A. Gay(15), Benjamin W. Fischer‐Valuck(13), Jeff M. Michalski(13), Lily Mahapatra(12), David J. Shapiro(11), Temitope Agabalogun(9), Chengjian Mao(7), Yi Huang(6), Mackenzie Daly(5), Amit Roy(5), Ruben Carmona(5), Xiaobin Zheng(4), Kelly M. MacArthur(4), H.B. Stowe(4), Michael R. Waters(4), Lauren E. Henke(4), William G. Helferich(3), Liqun Yu(3)